|
|||||
|
|
Safety,pharmacokinetics and pharmacodynamics of multiple‐ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus |
|
| Authors: | L. A. Morrow M. Leonsson‐Zachrisson H. Ericsson M. Wollbratt M. Knutsson M. Hompesch E. Norjavaara |
| Affiliation: | 1. Profil Institute for Clinical Research, , Chula Vista, CA, USA;2. AstraZeneca R&D, , M?Indal, Sweden |
| Abstract: | |
| Keywords: | glucokinase glucokinase activator type 2 diabetes mellitus |